Global Alprazolam Tablets Market – Dynamics
The increasing prevalence of anxiety among the world population is expected to drive growth of the global alprazolam tablets markets during the forecast period. For instance, according to the statistics published on 15th June 2020, the Center for Disease Control and Prevention, (CDC), reported that, globally, 7.1% of children in the age group of 3-17 years, or around 4.4 million children, have been diagnosed with anxiety. Furthermore, according to World Health Organization, (WHO), in 2018, around 264 million adults across the globe suffered from anxiety. Out of these, 63% were females and 37% were males.
Moreover, campaigns launched by regulatory authorities are expected to drive sales of original drugs rather than illegal copies of drug, and thereby boost growth of the global alprazolam tablets market. For instance, on 4th August 2020, the U.S. Drug Enforcement Administration (DEA), launched a campaign against the marketing of tablets production kits such as tablet presses, die punches, and chemicals used for illegal drug synthesis. According to the DEA, these kits may be used for making copies of brands marketing alprazolam tablets such as OxyContin or Xanax, by adding fentanyl, heroin, and isotonitazene, as active ingredients instead of alprazolam.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients